These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1062 related items for PubMed ID: 17430995
21. Interruption of nuclear factor kappaB signaling by the androgen receptor facilitates 12-O-tetradecanoylphorbolacetate-induced apoptosis in androgen-sensitive prostate cancer LNCaP cells. Altuwaijri S, Lin HK, Chuang KH, Lin WJ, Yeh S, Hanchett LA, Rahman MM, Kang HY, Tsai MY, Zhang Y, Yang L, Chang C. Cancer Res; 2003 Nov 01; 63(21):7106-12. PubMed ID: 14612503 [Abstract] [Full Text] [Related]
22. The role of protein kinase A pathway and cAMP responsive element-binding protein in androgen receptor-mediated transcription at the prostate-specific antigen locus. Kim J, Jia L, Stallcup MR, Coetzee GA. J Mol Endocrinol; 2005 Feb 01; 34(1):107-18. PubMed ID: 15691881 [Abstract] [Full Text] [Related]
23. Short hairpin RNA knockdown of the androgen receptor attenuates ligand-independent activation and delays tumor progression. Cheng H, Snoek R, Ghaidi F, Cox ME, Rennie PS. Cancer Res; 2006 Nov 01; 66(21):10613-20. PubMed ID: 17079486 [Abstract] [Full Text] [Related]
24. Regulation of FGF8 expression by the androgen receptor in human prostate cancer. Gnanapragasam VJ, Robson CN, Neal DE, Leung HY. Oncogene; 2002 Aug 01; 21(33):5069-80. PubMed ID: 12140757 [Abstract] [Full Text] [Related]
25. GCP-mediated growth inhibition and apoptosis of prostate cancer cells via androgen receptor-dependent and -independent mechanisms. Tepper CG, Vinall RL, Wee CB, Xue L, Shi XB, Burich R, Mack PC, de Vere White RW. Prostate; 2007 Apr 01; 67(5):521-35. PubMed ID: 17252539 [Abstract] [Full Text] [Related]
26. The androgen receptor and prostate cancer invasion. Bonaccorsi L, Muratori M, Marchiani S, Forti G, Baldi E. Mol Cell Endocrinol; 2006 Feb 26; 246(1-2):157-62. PubMed ID: 16376012 [Abstract] [Full Text] [Related]
27. Differential regulation by melatonin of cell growth and androgen receptor binding to the androgen response element in prostate cancer cells. Rimler A, Lupowitz Z, Zisapel N. Neuro Endocrinol Lett; 2002 Apr 26; 23 Suppl 1():45-9. PubMed ID: 12019351 [Abstract] [Full Text] [Related]
28. Vasoactive intestinal peptide induces cyclooxygenase-2 expression through nuclear factor-kappaB in human prostate cell lines Differential time-dependent responses in cancer progression. Fernández-Martínez AB, Collado B, Bajo AM, Sánchez-Chapado M, Prieto JC, Carmena MJ. Mol Cell Endocrinol; 2007 May 30; 270(1-2):8-16. PubMed ID: 17434257 [Abstract] [Full Text] [Related]
29. Novel steroid receptor phyto-modulator compound a inhibits growth and survival of prostate cancer cells. Yemelyanov A, Czwornog J, Gera L, Joshi S, Chatterton RT, Budunova I. Cancer Res; 2008 Jun 15; 68(12):4763-73. PubMed ID: 18559523 [Abstract] [Full Text] [Related]
30. Androgens induce prostate cancer cell proliferation through mammalian target of rapamycin activation and post-transcriptional increases in cyclin D proteins. Xu Y, Chen SY, Ross KN, Balk SP. Cancer Res; 2006 Aug 01; 66(15):7783-92. PubMed ID: 16885382 [Abstract] [Full Text] [Related]
31. Mechanisms of prostate cancer cell survival after inhibition of AR expression. Cohen MB, Rokhlin OW. J Cell Biochem; 2009 Feb 15; 106(3):363-71. PubMed ID: 19115258 [Abstract] [Full Text] [Related]
32. c-Jun enhancement of androgen receptor transactivation is associated with prostate cancer cell proliferation. Chen SY, Cai C, Fisher CJ, Zheng Z, Omwancha J, Hsieh CL, Shemshedini L. Oncogene; 2006 Nov 16; 25(54):7212-23. PubMed ID: 16732317 [Abstract] [Full Text] [Related]
34. Post-transcriptional regulation of the androgen receptor by Mammalian target of rapamycin. Cinar B, De Benedetti A, Freeman MR. Cancer Res; 2005 Apr 01; 65(7):2547-53. PubMed ID: 15805247 [Abstract] [Full Text] [Related]
35. Melatonin reduces prostate cancer cell growth leading to neuroendocrine differentiation via a receptor and PKA independent mechanism. Sainz RM, Mayo JC, Tan DX, León J, Manchester L, Reiter RJ. Prostate; 2005 Apr 01; 63(1):29-43. PubMed ID: 15378522 [Abstract] [Full Text] [Related]
36. Androgen receptor stabilization in recurrent prostate cancer is associated with hypersensitivity to low androgen. Gregory CW, Johnson RT, Mohler JL, French FS, Wilson EM. Cancer Res; 2001 Apr 01; 61(7):2892-8. PubMed ID: 11306464 [Abstract] [Full Text] [Related]
37. Inhibition of LncaP prostate cancer cells by means of androgen receptor antisense oligonucleotides. Eder IE, Culig Z, Ramoner R, Thurnher M, Putz T, Nessler-Menardi C, Tiefenthaler M, Bartsch G, Klocker H. Cancer Gene Ther; 2000 Jul 01; 7(7):997-1007. PubMed ID: 10917202 [Abstract] [Full Text] [Related]
38. Rap2 regulates androgen sensitivity in human prostate cancer cells. Bigler D, Gioeli D, Conaway MR, Weber MJ, Theodorescu D. Prostate; 2007 Oct 01; 67(14):1590-9. PubMed ID: 17918750 [Abstract] [Full Text] [Related]
39. Steroid hormonal regulation of growth, prostate specific antigen secretion, and transcription mediated by the mutated androgen receptor in CWR22Rv1 human prostate carcinoma cells. Attardi BJ, Burgenson J, Hild SA, Reel JR. Mol Cell Endocrinol; 2004 Jul 30; 222(1-2):121-32. PubMed ID: 15249132 [Abstract] [Full Text] [Related]
40. 5alpha-androstane-3alpha,17beta-diol supports human prostate cancer cell survival and proliferation through androgen receptor-independent signaling pathways: implication of androgen-independent prostate cancer progression. Yang Q, Titus MA, Fung KM, Lin HK. J Cell Biochem; 2008 Aug 01; 104(5):1612-24. PubMed ID: 18320593 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]